Linkens A E M J H, Milosevic V, van der Kuy P H M, Damen-Hendriks V H, Mestres Gonzalvo C, Hurkens K P G M
Department of Internal Medicine, Maastricht University Medical Centre, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
Department of Clinical Pharmacy, Pharmacology and Toxicology, Zuyderland Medical Centre, PO box 5500, 6130 MB, Sittard, The Netherlands.
Int J Clin Pharm. 2020 Oct;42(5):1243-1251. doi: 10.1007/s11096-020-01040-1. Epub 2020 May 30.
Background The number of medication related hospital admissions and readmissions are increasing over the years due to the ageing population. Medication related hospital admissions and readmissions lead to decreased quality of life and high healthcare costs. Aim of the review To assess what is currently known about medication related hospital admissions, medication related hospital readmissions, their risk factors, and possible interventions which reduce medication related hospital readmissions. Method We searched PubMed for articles about the topic medication related hospital admissions and readmissions. Overall 54 studies were selected for the overview of literature. Results Between the different selected studies there was much heterogeneity in definitions for medication related admission and readmissions, in study population and the way studies were performed. Multiple risk factors are found in the studies for example: polypharmacy, comorbidities, therapy non adherence, cognitive impairment, depending living situation, high risk medications and higher age. Different interventions are studied to reduce the number of medication related readmission, some of these interventions may reduce the readmissions like the participation of a pharmacist, education programmes and transition-of-care interventions and the use of digital assistance in the form of Clinical Decision Support Systems. However the methods and the results of these interventions show heterogeneity in the different researches. Conclusion There is much heterogeneity in incidence and definitions for both medication related hospital admissions and readmissions. Some risk factors are known for medication related admissions and readmissions such as polypharmacy, older age and additional diseases. Known interventions that could possibly lead to a decrease in medication related hospital readmissions are spare being the involvement of a pharmacist, education programs and transition-care interventions the most mentioned ones although controversial results have been reported. More research is needed to gather more information on this topic.
背景 由于人口老龄化,近年来与药物相关的住院和再入院人数不断增加。与药物相关的住院和再入院会导致生活质量下降和医疗成本高昂。综述目的 评估目前关于与药物相关的住院、与药物相关的再入院、其危险因素以及可减少与药物相关的再入院的可能干预措施的已知情况。方法 我们在PubMed上搜索了关于与药物相关的住院和再入院主题的文章。总共选择了54项研究进行文献综述。结果 在不同的所选研究中,与药物相关的入院和再入院的定义、研究人群以及研究开展方式存在很大异质性。研究中发现了多种危险因素,例如:多重用药、合并症、治疗依从性差、认知障碍、依赖生活状况、高风险药物和高龄。研究了不同的干预措施以减少与药物相关的再入院次数,其中一些干预措施可能会减少再入院次数,如药剂师的参与、教育项目、护理过渡干预以及以临床决策支持系统形式使用数字辅助工具。然而,这些干预措施的方法和结果在不同研究中显示出异质性。结论 与药物相关的住院和再入院的发生率及定义存在很大异质性。已知一些与药物相关的入院和再入院的危险因素,如多重用药、老年和其他疾病。已知可能导致与药物相关的住院再入院次数减少的干预措施,尽管有争议的结果被报道,但药剂师的参与、教育项目和护理过渡干预是最常被提及的。需要更多研究来收集关于该主题的更多信息。